Womble Perspectives

Welcome back to Womble Perspectives. Today’s episode is the second in a series focusing on the complex world of international trade. From shifting tariff policies to trade agreements, we’re exploring the forces shaping global trade. Whether you’re a seasoned economist, business leader, or simply curious about how trade impacts your daily life, this series will bring you the insights you need to stay informed. 

In case you missed part 1, you can find it here.

About our guests

• Alan Enslen
• Rob Jenkins
• Peter Snaith

About Womble's International Trade and National Security practice

About Barbourne Brook

On July 31st, 2025, the U.S. Food and Drug Administration announced sweeping changes to the safety labeling of all opioid pain medications. These updates aim to better communicate the risks of long-term opioid use—risks that include misuse, addiction, overdose, and a range of serious side effects.

For drug manufacturers, this means updating product labels to help patients, doctors, pharmacists, and other healthcare providers make more informed decisions. But the implications go far beyond packaging—they touch on the very science of how opioids interact with the human body.

Read the full article

• FDA Requires Drug Manufacturers to Update Prescribing Information for Opioid Pain Medicines

About the author

• L. Christine Lawson

Today’s episode sits at the intersection of culture, commerce, and creativity, diving into a trademark dispute that’s got both the fashion and music industries watching closely. It’s a case that asks: Can a rock band’s name really confuse consumers into thinking they’re buying luxury jewelry?

Read the full article

• He Has His Heart of Gold…. Why Not a Chrome Heart, Too?

About the author

• Lori B. Cohen

Welcome back to Womble Perspectives. Today’s episode is the first in a series focusing on the complex world of international trade. From shifting tariff policies to trade agreements, we’re exploring the forces shaping global trade. Whether you’re a seasoned economist, business leader, or simply curious about how trade impacts your daily life, this series will bring you the insights you need to stay informed. 

About our guests

• Alan Enslen
• Rob Jenkins
• Peter Snaith

About Womble's International Trade and National Security practice

About Barbourne Brook

Today’s episode is part of our Recruiting Success stories series. Lori Patton, our Chief Recruiting Officer, sits down with Tomio Narita, a partner in our San Francisco office and co-leader of the firm’s Class Action Defense Team.

More about WBD's Class Action Litigation practice.

Recently, the White House and the FDA issued statements suggesting a possible connection between prenatal acetaminophen exposure and increased risks of autism and ADHD. These announcements have prompted strong reactions from the scientific community. Organizations like The American College of Obstetricians and Gynecologists and The World Health Organization have responded with caution, emphasizing that the current evidence does not support a definitive causal link.

So, what does the science actually say?

Read the full article

• Autism and Acetaminophen Use during Pregnancy: Does Science Support the Claim of a Link?

About the author

• Matt Quinn, Ph.D.

Today, we’re diving into the ripple effects of the One Big Beautiful Bill Act and what it means for the data center sector.

Read the full article

• OBBBA’s Ripple Effect: Strategic Implications for the Data Center Sector

About the authors

• Kristina Moore
• Stephen Snyder
• David Beckstead
• Trevor Tomlinson

Aldi, the discount supermarket chain, has built a strong and growing fan base. It’s on track to open over 225 new stores this year, positioning itself as a low-cost alternative to traditional brands. You’ve probably heard their former slogan: “Like brands, only cheaper.” That’s the heart of their business model—offering private-label products that resemble national brands, but at a lower price.

Read the full article
Snack Wars: Mondelez Challenges Aldi’s Packaging Design Strategy in Trademark Infringement Lawsuit

About the authors
Sara M. Bauer
Stephanie Smiertka Riley

Today, we’re diving into an international legal battle that’s been making its way through the gaming world: a patent dispute between Nintendo and the creators of Palworld.

Read the full article

• Gotta Catch ’Em All...In Court?: Nintendo Bolsters U.S. Patent Portfolio In Wake of Japanese Lawsuit Against Pocketpair

About the authors

• Reid Barber
• John H. Wright, III

Welcome to today’s episode of Womble Perspectives, where we’ll be diving into how artificial intelligence is helping shape the health care landscape.

As in other industries, AI can be a powerful ally for healthcare professionals. From organizing medical records to streamlining medication management and simplifying clinical documentation, AI is helping clinicians save time and improve accuracy. 

But how far can things go before AI’s helping hand turns into liability?

Read the full article

• AI Chatbots in the Medical Field: Healthcare Hero or HIPAA Nightmare?

About the author

• Amy Hill